Literature DB >> 33448667

Teledermatology in the times of COVID-19 - a systematic review.

Peter Elsner1.   

Abstract

The COVID-19 pandemic restricts the care of dermatological patients in many ways. Teledermatology such as video consultation or "store-and-forward" teledermatology could at least partly compensate for this. This systematic review summarizes all published studies on teledermatology during the COVID-19 pandemic. It is based on a MEDLINE search for articles from 2020 in English and German. Two surveys among dermatologists from the USA and India showed that more than 80 % offered teledermatology. Among German dermatologists 17.5 % of 480 respondents offered online video consultation, 11.3 % offline consultation (store and forward) and 10.0 % both. Five cohort studies on teledermatology during the pandemic were identified. Three of them investigated teledermatology in chronic dermatoses (acne, inflammatory skin diseases), one dealt with the care of oncological patients with dermatological complications, and one analyzed teleconsultation in suspected COVID-19 cases. In all studies, teledermatology largely reduced the number of personal consultations. The results indicate that the limitations of personal dermatological care of patients with skin diseases during the COVID-19 pandemic can be at least partially compensated by an extension of teledermatology. Findings from the use of teledermatology during the pandemic should be employed to improve the use and acceptance of teledermatology by patients and dermatologists.
© 2020 The Authors. Journal der Deutschen Dermatologischen Gesellschaft published by John Wiley & Sons Ltd on behalf of Deutsche Dermatologische Gesellschaft.

Entities:  

Year:  2020        PMID: 33448667     DOI: 10.1111/ddg.14180

Source DB:  PubMed          Journal:  J Dtsch Dermatol Ges        ISSN: 1610-0379            Impact factor:   5.584


  15 in total

1.  Implementing High-Quality Primary Care Through a Health Equity Lens.

Authors:  Azza Eissa; Robyn Rowe; Andrew Pinto; George N Okoli; Kendall M Campbell; Judy C Washington; José E Rodríguez
Journal:  Ann Fam Med       Date:  2022-02-14       Impact factor: 5.166

2.  Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.

Authors:  William J Nahm; Eran C Gwillim; Evangelos V Badiavas; Anna J Nichols; Robert S Kirsner; Laurence H Boggeln; John T Shen
Journal:  Dermatol Ther (Heidelb)       Date:  2021-01-17

3.  Public interest in dermatologic symptoms, conditions, treatments, and procedures during the COVID-19 pandemic: Insights from Google Trends.

Authors:  Kübra Esen-Salman; Özlem Akın-Çakıcı; Sinan Kardeş; Andaç Salman
Journal:  Dermatol Ther       Date:  2021-02-25       Impact factor: 3.858

Review 4.  Teledermatology During COVID-19: An Updated Review.

Authors:  Morgan A Farr; Madeleine Duvic; Tejas P Joshi
Journal:  Am J Clin Dermatol       Date:  2021-04-09       Impact factor: 6.233

5.  Single-center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic.

Authors:  Soichiro Kado; Koji Kamiya; Megumi Kishimoto; Takeo Maekawa; Aya Kuwahara; Junichi Sugai; Mayumi Komine; Mamitaro Ohtsuki
Journal:  J Dermatol       Date:  2021-09-21       Impact factor: 4.005

6.  Evaluating paediatric dermatology telephone clinics during COVID-19 from a dual clinician and patient perspective: a prospective study.

Authors:  A Lowe; S Dawood; A Al-Tayeb; P Hancock; A Pararajasingam; F Ali; R G Goodwin
Journal:  Clin Exp Dermatol       Date:  2021-11-22       Impact factor: 4.481

Review 7.  [Areas of application for teledermatology].

Authors:  P Reinders; M Otten; M Augustin; B Stephan; N Kirsten
Journal:  Hautarzt       Date:  2021-11-05       Impact factor: 1.198

Review 8.  Teledermatology in the time of COVID-19.

Authors:  Ahmed Elsayed Ibrahim; Mayar Magdy; Eslam M Khalaf; Alshimaa Mostafa; Ahmed Arafa
Journal:  Int J Clin Pract       Date:  2021-11-04       Impact factor: 3.149

Review 9.  Biologics for Psoriasis during the COVID-19 Pandemic.

Authors:  Koji Kamiya; Mayumi Komine; Mamitaro Ohtsuki
Journal:  J Clin Med       Date:  2021-03-30       Impact factor: 4.241

10.  Use of and Satisfaction with Telemedicine Services during the Pandemic: Findings from the COVID-19 Snapshot Monitoring in Germany (COSMO).

Authors:  André Hajek; Freia De Bock; Christina Merkel; Benedikt Kretzler; Hans-Helmut König
Journal:  Healthcare (Basel)       Date:  2022-01-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.